Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 151 entries
View as:

Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults

Phase: N/A Priority: Normal
NCT ID: NCT02174978 Org: User:
Start: 08/31/14 End: 10/31/15 Due: 10/31/16

Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children

Phase: N/A Priority: Normal
NCT ID: NCT00317473 Org: User:
Start: 06/30/03 End: 07/31/05 Due: 07/31/06

Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults

Phase: N/A Priority: Normal
NCT ID: NCT02421367 Org: User:
Start: 08/31/15 End: 03/31/18 Due: 03/31/19

A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparum

Phase: N/A Priority: Normal
NCT ID: NCT02488902 Org: User:
Start: 08/31/98 End: 03/31/03 Due: 03/31/04

Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03051386 Org: User:
Start: 05/30/18 End: 04/01/23 Due: 04/01/24

NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1

Phase: N/A Priority: Normal
NCT ID: NCT00392015 Org: User:
Start: 10/12/06 End: 09/25/17 Due: 09/25/18

Booster Dose (50 µg) of Recombinant Ricin Toxin Vaccine (RVEc™) in Previously Vaccinated Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01846104 Org: User:
Start: 04/30/13 End: 06/30/13 Due: 06/30/14

HIV Vaccine in HIV-uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT04658667 Org: User:
Start: 01/18/22 End: 05/31/27 Due: 05/31/28

Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama

Phase: N/A Priority: Normal
NCT ID: NCT01790659 Org: User:
Start: 05/31/13 End: 01/31/16 Due: 01/31/17

TDENV PIV and LAV Dengue Prime-boost Strategy

Phase: N/A Priority: Normal
NCT ID: NCT02239614 Org: User:
Start: 12/31/14 End: 02/17/17 Due: 02/17/18

Safety and Immunogenicity Study of Recombinant Ricin Toxin A-Chain Vaccine (RVEc™)

Phase: N/A Priority: Normal
NCT ID: NCT01317667 Org: User:
Start: 03/31/11 End: 12/31/14 Due: 12/31/15

Questionnaire Study to Assess Quality of Life After Treatment of Fibroids

Phase: N/A Priority: Normal
NCT ID: NCT00390494 Org: User:
Start: 12/31/05 End: 12/31/10 Due: 12/31/11

Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease

Phase: N/A Priority: Normal
NCT ID: NCT01502735 Org: User:
Start: 12/31/11 End: 09/30/13 Due: 09/30/14

Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever

Phase: N/A Priority: Normal
NCT ID: NCT02483260 Org: User:
Start: 06/16/16 End: 12/31/28 Due: 12/31/29

Treatment of Hemorrhagic Fever With Ribavirin

Phase: N/A Priority: Normal
NCT ID: NCT04283513 Org: User:
Start: 10/31/22 End: 07/31/27 Due: 07/31/28

PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04784767 Org: User:
Start: 04/05/21 End: 10/30/23 Due: 10/30/24

Combination HTNV and PUUV DNA Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT03718130 Org: User:
Start: 07/10/19 End: 10/07/22 Due: 10/07/23

Use of Sodium Stibogluconate as a Treatment for Leishmaniasis

Phase: N/A Priority: Normal
NCT ID: NCT00657618 Org: User:
Start: 10/31/04 End: 04/30/15 Due: 04/30/16

A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants

Phase: N/A Priority: Normal
NCT ID: NCT00322049 Org: User:
Start: 02/29/04 End: 06/30/09 Due: 06/30/10

A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00412477 Org: User:
Start: 08/20/04 End: 11/01/06 Due: 11/01/07

Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama

Phase: N/A Priority: Normal
NCT ID: NCT01083576 Org: User:
Start: 03/31/10 End: 07/31/11 Due: 07/31/12

Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT01502345 Org: User:
Start: 01/31/12 End: 01/31/13 Due: 01/31/14

Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT01382095 Org: User:
Start: 07/31/11 End: 04/30/13 Due: 04/30/14

Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT01540474 Org: User:
Start: 02/29/12 End: 12/31/12 Due: 12/31/13

A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children

Phase: N/A Priority: Normal
NCT ID: NCT00468858 Org: User:
Start: 07/31/07 End: 04/30/10 Due: 04/30/11